Understanding how Smad4 regulates the corneal stroma
Smad4 is a master regulator for extracellular matrix homeostasis in the corneal stroma
This study is looking at how a protein called Smad4 helps keep the cornea healthy and clear, which is important for good vision, and it's for anyone interested in understanding more about corneal diseases and potential new treatments.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11035627 on NIH RePORTER |
What this research studies
This research investigates the role of Smad4 in maintaining the balance of the extracellular matrix (ECM) in the corneal stroma, which is crucial for clear vision. By studying genetically modified mice, the researchers aim to understand how disruptions in Smad4 affect corneal structure and function. The approach involves examining the differences in corneal thinning between mice lacking Smad4 and those lacking another receptor, Tbr1, to uncover the mechanisms behind ECM synthesis and degradation. This could lead to insights into potential treatments for corneal diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with corneal thinning or other related ocular conditions.
Not a fit: Patients with corneal conditions unrelated to ECM homeostasis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for corneal disorders that affect vision.
How similar studies have performed: Previous research has shown that targeting the TGF-β signaling pathway can lead to significant advancements in understanding corneal health, suggesting this approach may yield valuable insights.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Liu, Chia-Yang — University of Cincinnati
- Study coordinator: Liu, Chia-Yang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.